Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 November, 2018 20:01 IST
Sun Pharma arm Dusa files lawsuit against Biofrontera
Source: IRIS | 12 Jul, 2018, 11.01AM
Comments  |  Post Comment

DUSA Pharmaceuticals, Inc., (DUSA) a wholly owned subsidiary of Sun Pharmaceutical Industries announced that DUSA has filed trade secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit against Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG in the United States District Court for the District of Massachusetts.

The lawsuit alleges patent infringement of DUSA's patents, US 9,723,991 and US 8,216,289 covering DUSA's product, LEVULAN KERASTICK (aminolevulinic acid HCl) for topical solution, 20% used with DUSA's BLU-U Blue Light Photodynamic Therapy Illuminator.

In its amended complaint, DUSA additionally alleges that the Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained confidential DUSA information from former DUSA employees to sell and market defendants' own products. The lawsuit seeks an assessment of both damages and injunctive relief against the Biofrontera defendants.

The patents-in-suit concern an apparatus and method for ''photodynamic therapy'' (or PDT) and equipment for PDT. The photodynamic therapy, pioneered by DUSA, combines a drug with a light source to treat disease conditions. The product was launched by DUSA in September 2000 in the US.

Shares of the company gained Rs 8.2, or 1.46%, to trade at Rs 569.00. The total volume of shares traded was 84,955 at the BSE (10.48 a.m., Thursday).



Sun Pharmaceutical Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Gayatri Projects declared as lowest bidder for project worth Rs 1.62 bn - 20-Nov-2018 14:55
Ramco Systems wins contract from leading casino and resorts provider - 20-Nov-2018 14:52
Zydus Cadila receives tentative approval for Deferasirox tablets - 20-Nov-2018 14:49
Kridhan Infra arm wins orders worth Rs 1.95 bn - 20-Nov-2018 09:35
Glenmark Pharma receives approval for Azelaic acid gel - 20-Nov-2018 09:31
TCS partners with SAP to build intelligent rail digital maintenance solution - 20-Nov-2018 09:27
Vikas Ecotech to explore strategic inorganic growth opportunity - 19-Nov-2018 09:54
Zydus receives final approval from USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection - 19-Nov-2018 09:51
Infosys starts construction of U.S education center in Indianapolis - 19-Nov-2018 09:41
Infosys completes formation of JV with Temasek - 19-Nov-2018 09:37
SPML Infra wins arbitration award against Jharkhand Urja Utpadan Nigam - 19-Nov-2018 09:34
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer